EMA Updates Recommendations for Blood Clot Treatment Trials

Clinical Trials Advisor
A A
The European Medicines Agency is revising the way drugmakers conduct studies for drugs to treat blood clots, for the first time separating out the clinical requirements for different types of clots.

To View This Article:

Login

Subscribe To Clinical Trials Advisor